• KIPA: Engineering - electronics, optics, mechanics, spectroscopy, aerospace, microfluidics ...
  • KIPA: Biotechnology - drug screens, assays, extractions, peptides, nucleic acids, natural products
  • Legal and Litigation Support – sub text: infringement, invalidity, licensing, FTO, due diligence
  • Medical Devices -  sub text: occluders, implants, stents, photodynamic therapy, anesthesia equipment, heart-lung machines

On the 13 – 15 of October 2015 INTA – the International Trademark Association – for the first time held their annual TMAP Meeting in Europe. The TMAP meeting is for Trade Mark Administrators and Practioners, providing Continued legal training for professionals.
This time the meeting focus was on the Community Trademark and was held in cooperation with the OHIM office in Alicante, Spain.

KIPA sent two representatives to stay up to date on coming changes in the legislation for European trademarks and designs. The office changes it’s name from OHIM to EUIPO during the course of 2016 and there will be several changes in the legislation that might have a more material impact on our clients.
[Continue Reading…]

The Court of Justice of the European Union has ruled that owners of standard-essential patents (SEPs) should make a licensing offer on fair, reasonable and non-discriminatory (FRAND) terms before seeking an injunction against the alleged infringement of a SEP. In the eagerly awaited judgment, handed down July 16th 2015, the Court of Justice of the European Union (CJEU) ruled on the Huawei v ZTE case. The judgement provides a balance between standard-essential patent (SEP) owners’ and implementers’ interests. …
[Continue Reading…]